Work Here?
Overview
Zifo provides tailored scientific informatics services across Laboratory/R&D, Manufacturing, and Trial operations to help science-driven organizations discover, develop, manufacture, and test products. It offers Digital Transformation Coaching, Business Analysis, Program & Project Management, Managed Services, Validation, and Custom Development & Integrations, backed by expertise in Chem & Bioinformatics, Data Science, Cloud, HPC, MultiOmics, Data Modeling, Semantics, and AI/ML. It differentiates itself by combining deep scientific domain knowledge with end-to-end informatics capabilities, from transformation coaching to validation and integrations, for research, development, manufacturing, and trials. Its goal is to empower customers to advance science and technology while improving global health and wellbeing.
About Zifo
Industries
Data & Analytics
Consulting
Enterprise Software
Healthcare
Company Size
1,001-5,000
Company Stage
Growth Equity (Non-Venture Capital)
Total Funding
$250M
Headquarters
New York
Founded
2008
Simplify's Take
What believers are saying
- AI orchestration can reduce manual handoffs and data-entry errors in labs.
- The IVP Assay Repository expands Zifo into industry standards and reusable data infrastructure.
- Regulated-workflow automation fits toxicology, validation, audit trails, and CMC submission drafting.
What critics are saying
- Accenture and Deloitte can bundle informatics services into broader transformation contracts.
- Veeva-style platform owners can compress Zifo’s integration layer with native workflows.
- A single GxP AI defect can trigger customer trust loss and rollout delays.
What makes Zifo unique
- Zifo combines scientific informatics with Practical AI across R&D, manufacturing, and clinical workflows.
- Its 2,300-employee global team spans 90 partner technologies and 190+ customers.
- Zifo builds compliance-ready accelerators for ELNs, LIMS, CDS, and instrument data.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$250M
Above
Industry Average
Funded Over
1 Rounds
Growth & Insights and Company News
6 month growth
↓ -3%1 year growth
↓ -3%2 year growth
↓ -3%Zifo, a global enterprise informatics provider, has partnered with Maze Therapeutics to manage and scale biobank data for precision medicine research. The collaboration addresses challenges researchers face with static tools when working with massive genetic and phenotypic datasets from sources like UK Biobank and All of Us Research Program. Zifo's translational genomics platform integrates AI-enabled workflows, providing researchers with a dynamic system that connects genetic signals, biological pathways and phenotypes. The solution can render summary statistics in under five seconds and is designed to accommodate new biobank data, making it AI-ready for future applications in protein modelling and genotype-phenotype mapping. Maze Therapeutics, a clinical-stage biopharmaceutical company, is using the platform to accelerate target identification and validation work in kidney and metabolic diseases.
CDISC 2025 AI Innovation Challenge: AI blueprints by Zifo earn runner-up position.
Zifo launches AI antibody engineering app on snowflake marketplace to accelerate biologics and drug discovery.
Integration will reduce the burden of master lab data configuration, lowering costs and speeding Veeva LIMS implementationBARCELONA, Spain and DEERFIELD, Ill., Jan. 23, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) and Zifo today announced a product partnership to help biopharmas modernize quality control (QC) operations. By bringing together Veeva LIMS with Zifo's data integration and management platform, qcKen, companies can import data directly from any source document or other LIMS into Veeva LIMS. This integration will simplify master data configuration during LIMS implementation and site deployment, making it easier for companies to advance beyond legacy QC systems."We are excited to partner with Veeva to offer powerful solutions to the life sciences industry," said Kannan Jagamoorthy, general manager and head of Zifo North America. "Our collaboration will help customers expedite their adoption of Veeva LIMS to streamline operations."With Veeva, companies take a holistic approach to quality assurance (QA) and QC to support GMP quality business processes with greater accuracy. Using Zifo's qcKen will help accelerate test and specification data creation, streamline implementation and site deployments, and deliver a faster return on investment for new Veeva LIMS customers."Veeva LIMS is designed specifically for life sciences organizations looking to advance their QC operations, increase scale, and speed batch release cycles," said Ashley McMillan, senior director, Veeva LIMS strategy
Veeva partners with Zifo to modernize QC in life sciences.
There are no jobs for Zifo right now.
Find jobs on Simplify and start your career today
About Zifo
Industries
Data & Analytics
Consulting
Enterprise Software
Healthcare
Company Size
1,001-5,000
Company Stage
Growth Equity (Non-Venture Capital)
Total Funding
$250M
Headquarters
New York
Founded
2008
There are no jobs for Zifo right now.
Find jobs on Simplify and start your career today